Every medical device company needs a Quality Management System (QMS), but for startups and small teams, over-engineering the QMS is one of the fastest ways to kill development velocity. The goal is a lean, compliant system that satisfies both ISO 13485:2016 and regulatory requirements without creating unnecessary bureaucratic overhead. With the FDA QMSR taking effect on February 2, 2026, ISO 13485 alignment is now mandatory for the US market as well.
ISO 13485:2016 — What’s Truly Mandatory
ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements. The standard is organized into eight clauses, with clauses 4 through 8 containing the auditable requirements.
The mandatory requirements cover:
- Clause 4 — QMS: Documentation requirements, quality manual, document control, record control.
- Clause 5 — Management responsibility: Quality policy, planning, management review, management representative.
- Clause 6 — Resource management: Personnel competence, infrastructure, work environment.
- Clause 7 — Product realization: Design controls, purchasing, production, servicing, monitoring and measurement.
- Clause 8 — Measurement, analysis, improvement: Monitoring, internal audits, nonconforming product control, CAPA, data analysis.
However, ISO 13485 allows you to exclude requirements that are not applicable to your activities, provided you justify the exclusion. For example, if you do not perform servicing, you can exclude those requirements. The key is to document what you exclude and why.
FDA QMSR: Why ISO 13485 Now Matters for the US
On February 2, 2026, the FDA’s Quality Management System Regulation (QMSR) replaced the legacy 21 CFR Part 820 (current Good Manufacturing Practice). The QMSR incorporates ISO 13485:2016 by reference, meaning that compliance with ISO 13485 is now the basis for FDA QMS compliance.
This is a significant development for startups planning dual US/EU market entry. Previously, companies often maintained two parallel quality systems. With QMSR, a single ISO 13485-based QMS can serve both markets, reducing overhead substantially.
Note: The QMSR adds FDA-specific requirements on top of ISO 13485, including complaint handling timelines, MDR reporting, and establishment registration. You still need to address these supplemental requirements, but the core QMS structure is now shared.
The Lean Approach: Start with 12–15 Core SOPs
A common mistake for startups is purchasing a template QMS with 50+ procedures and trying to implement everything at once. This leads to procedures that nobody follows, records that are never generated, and an audit trail that collapses under scrutiny. Instead, start lean with the minimum set of procedures you actually need.
Core SOPs for a startup QMS (recommended minimum):
- Document Control — How you create, review, approve, distribute, and revise controlled documents.
- Record Control — How you identify, store, protect, retrieve, and dispose of quality records.
- Management Review — How management reviews QMS effectiveness at planned intervals (at least annually).
- Training and Competence — How you identify training needs, deliver training, and verify competence.
- Design and Development Control — How you plan, review, verify, validate, and transfer your device design. This is the most critical SOP for a startup.
- Risk Management — Your ISO 14971-aligned process for hazard identification, risk estimation, risk evaluation, risk control, and residual risk assessment.
- Purchasing and Supplier Qualification — How you select, evaluate, and monitor suppliers and purchased components.
- Production and Process Control — How you control manufacturing processes, including process validation for special processes.
- Inspection and Testing — Incoming, in-process, and final inspection/testing requirements.
- Nonconforming Product Control — How you identify, segregate, evaluate, and disposition nonconforming product.
- CAPA (Corrective and Preventive Action) — How you investigate problems, identify root causes, implement corrections, and verify effectiveness.
- Internal Audit — How you plan and conduct internal audits to verify QMS conformity.
- Complaint Handling — How you receive, evaluate, investigate, and resolve customer complaints, including reportable event assessment.
- Post-Market Surveillance — How you proactively collect and analyze post-market data (required by both EU MDR and QMSR).
Start with these, use them, generate records, and expand only when your operations require it. A QMS that lives on paper but not in practice will fail any serious audit.
Cost Estimates for Certification
Realistic cost ranges for small companies seeking ISO 13485 certification:
- QMS development and implementation: $15K–$40K if using a consultant; less if you build in-house with templates and expertise.
- Initial certification audit (Stage 1 + Stage 2): $10K–$25K depending on the certification body, company size, and scope.
- Annual surveillance audits: $5K–$15K per year.
- Recertification (every 3 years): $8K–$20K.
- eQMS software: $200–$2,000/month for cloud-based platforms suited to startups.
Tip: Cloud-based eQMS platforms designed for startups (such as Qualio, Greenlight Guru, or similar) can significantly reduce the overhead of document and record management compared to paper-based or file-share systems.
Common First-Time Audit Findings
Certification auditors consistently find these issues in first-time ISO 13485 audits of small companies:
- Incomplete design history files: Missing design reviews, incomplete verification/validation records, or design changes not properly controlled. Start design controls from day one.
- Training records gaps: Staff performing quality-affecting activities without documented evidence of competence. Keep training records current.
- Supplier management gaps: Using components from unapproved or unqualified suppliers. Establish supplier qualification criteria before placing orders.
- CAPA system immaturity: No CAPAs opened, or CAPAs opened without root cause investigation or effectiveness verification. A CAPA system must be used to be compliant.
- Management review not conducted: Management review is a specific requirement with defined inputs and outputs. Schedule and conduct it at least annually with documented minutes.
Supporting Both EU MDR and FDA Simultaneously
A well-structured ISO 13485 QMS serves as the foundation for both EU MDR and FDA compliance. Here is how the requirements map:
- Design controls: ISO 13485 Clause 7.3 covers design and development. EU MDR Annex II requires technical documentation following a design control process. FDA QMSR requires design controls per ISO 13485.
- Risk management: ISO 14971 is referenced by both EU MDR (Annex I GSPR) and FDA QMSR. Use a single risk management process.
- Post-market surveillance: EU MDR requires PMS plans and reports. FDA QMSR requires complaint handling and MDR reporting. Build a unified PMS system that feeds both.
- CAPA: Required by both systems. A single CAPA process can serve both, with appropriate flagging for regulatory reporting thresholds.
Track your QMS implementation milestones
Use our Submission Tracker to organize your QMS documentation, audit schedules, and certification milestones.
Go to Tools